Author: Laticia Garcia

Inquiry into Women’s Pain in Australia Reveals Significant Healthcare Gaps A groundbreaking inquiry conducted by the Victorian government’s Women’s Health Advisory Council has unveiled alarming issues regarding the treatment of women’s pain within the Australian healthcare system. The inquiry, which ran from January to October 2024, gathered over 13,000 responses from women, healthcare professionals, and research organizations. Key Findings of the Inquiry The report, released recently, exposed widespread experiences among women of being dismissed or poorly treated in healthcare settings. It emphasizes the significant historical underfunding of women’s health research, leading to inadequate treatments for conditions such as endometriosis, arthritis,…

Read More

Empowering Expectant Mothers at Rikers Island A Unique Support Program Pregnancy is an intense journey, and for women who find themselves incarcerated, the challenges can be even more daunting. A Brooklyn-based initiative is addressing these challenges head-on, partnering with Rikers Island to provide much-needed care and connection for expectant mothers. Inspiring Change from Within Inside a nurturing environment filled with toys and books, Sophia Martin navigates her pregnancy with guidance from her doula. “Hopefully everything will be good, and he’ll be nice, big and healthy,” Martin expressed. “He’s definitely moving a lot. I feel like I’m ready, but not right…

Read More

The Gender Disparity in Sleep Quality: Insights and Solutions Sleep is a cornerstone of overall health and well-being, influencing both physical and cognitive functions. While we are all aware of the importance of a good night’s rest, studies indicate that women face unique challenges that often lead to disrupted sleep compared to men. According to research highlighted by Curely, an online pharmacy, women are more likely to experience disturbed sleep patterns. Understanding the Differences: Sleep Disruption in Women The Sleep Foundation corroborates this finding, noting that “women are also thought to be more vulnerable to health effects from poor sleep,…

Read More

Nebraska Governor Curbs Medicaid Support for Planned Parenthood November 6, 2025 In a significant move on Thursday, Nebraska Governor Jim Pillen issued an executive order that terminates Medicaid funding for Planned Parenthood clinics in the state. This action comes shortly after Nebraska voters approved a 12-week abortion ban last fall, signaling a continued tightening of abortion access in the region. Reactions to the Executive Order State officials praised the order as a win for fetal rights. Attorney General Mike Hilgers stated, “Today is a really, really good day. It’s a great day for Nebraska families. It’s a great day for…

Read More

Marissa Bode: Paving the Way for Inclusivity in Hollywood 2 min read At the age of 25, actress Marissa Bode is breaking barriers within the film industry, having made her mark as the first wheelchair user to portray Nessarose in the 2022 adaptation of *Wicked*. This milestone follows her years of dedication to acting, which began when she was just eight years old. Using Her Voice for Change Bode advocates for greater representation of disabled individuals in Hollywood, emphasizing the importance of seeing characters that do not solely focus on disability. “Something I—and several of my other disabled peers—have been…

Read More

AI’s Impact on Women’s Health: Covera Health’s Upcoming Forum NEW YORK, Nov. 5, 2025 — Covera Health is set to host its next Quality Rounds, a virtual forum series dedicated to enhancing healthcare quality. Event Overview The upcoming session, titled “Will AI Transform the Future of Women’s Health?”, aims to delve into practical applications of artificial intelligence in the early detection of critical health issues, including: Breast cancer Cardiovascular risk Bone health Scheduled for November 14, 2025, from 12:00 to 1:15 p.m. ET, this 45-minute virtual event is free to attend, but registration is required. Session Highlights During the forum,…

Read More

Health In Tech Unveils Key Panel for Davos 2026 In a significant announcement, Health In Tech is set to host a compelling discussion panel at the upcoming Davos 2026 event, titled “First Ladies: Backing Women Who Build.” This initiative aims to elevate the visibility of women’s contributions in technology and entrepreneurship. Featured Speaker: Cherie Blair CBE, KC The panel will feature Cherie Blair, a prominent advocate for women’s rights and Founder of the Cherie Blair Foundation for Women. Her extensive experience in law and international advocacy positions her as a vital voice in addressing gender disparities in the tech sector.…

Read More

Survey Highlights Holiday Stress and Its Impact on Gut Health NEW YORK, Nov. 4, 2025 — Oshi Health A recent survey conducted by YouGov on behalf of Oshi Health reveals a significant correlation between holiday-induced stress and gastrointestinal (GI) issues, particularly among women and mothers. The findings indicate that financial worries and overeating are leading causes of digestive health problems experienced during the holiday season. The Burden of Holiday Responsibilities The survey identified what it refers to as “Holiday CEOs,” a term highlighting individuals, predominantly women, who take on the lion’s share of holiday planning and responsibilities. Women accounted for…

Read More

New Insights from The Menopause Society’s 2025 Annual Meeting The recent Annual Meeting of The Menopause Society brought to light significant advancements in understanding menopausal hormone therapy (MHT). Key areas of exploration included the neuroprotective potential of MHT, alongside its roles in managing weight and cardiovascular health. Influence of Timing on Alzheimer’s Disease Biomarkers Research presented delved into the timing of hormone therapy in relation to Alzheimer’s disease biomarkers, suggesting a potential link that could influence future treatment strategies. Combining Hormone Therapy with Tirzepatide Recent studies examined the efficacy of combining hormone therapy with tirzepatide, a dual GLP-1/GIP agonist that…

Read More

Aspira Women’s Health Expands Ovarian Disease Diagnostics with UTMB Partnership Aspira Women’s Health, a pioneering bio-analytical company focusing on diagnostics for gynecological diseases, has secured a significant laboratory services agreement with the University of Texas Medical Branch at Galveston (UTMB Galveston). This partnership, which spans over 12 months, marks a pivotal achievement in Aspira’s strategic marketing initiatives targeting large healthcare organizations. Strategic Collaboration for Enhanced Diagnostics The agreement aims to broaden the reach of Aspira’s flagship diagnostic products, Ova1Plus and OvaWatch, within the Texas healthcare landscape. This collaboration seeks to facilitate early detection and management of ovarian diseases, effectively increasing…

Read More